Aquagene

Alachua, United States Founded: 1996 • Age: 30 yrs
Produces high-quality recombinant proteins for research and industrial applications.

About Aquagene

Aquagene was a Healthcare company based in Alachua (United States) founded in 1996. It produces high-quality recombinant proteins for research and industrial applications. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Recombinant Proteins and Production and Manufacturing. Its competitors include Encodia, Tierra Biosciences and Amide Technologies; 3 of its 3 listed competitors have raised funding.

Company details

Aquagene produces high-quality recombinant proteins for research and industrial applications, focusing on providing healthcare solutions, advancing biotech innovations, recombinant proteins, and production and manufacturing. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

  • Headquarters Alachua, United States
  • Sectors
    Healthcare
  • Website aquagene.com
Key Metrics

Funding Insights of Aquagene

  • Total Rounds 2
  • Last Round Unspecified β€” $400,000
  • First Round $580,000

    (Jun 2000)

  • Investors Count 1

All 2 funding rounds of Aquagene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2001$400,000Unspecified––
Jun 2000$580,000Unspecified––
Valuation history

1 investors in total: 1 institutional.

Investors in Aquagene

Aquagene has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advantage Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity investment firm
advantagecap.comNew Orleans, United States
Premium access

Investor details for Aquagene

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Aquagene

3 dated milestones of Aquagene across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aquagene is founded.
  2. Funding First funding round of $580K.
  3. Funding Latest funding round, Unspecified, of $400K.

Competitors of Aquagene

Aquagene has 3 listed competitors in our database, 3 of them funded. They include Encodia, Tierra Biosciences and Amide Technologies.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
encodia.com2015San Diego, United States$75M85
Technology platforms for integrative proteomic analysis are developed.
tierrabiosciences.com2015Berkeley, United States$31.56M11
AI-based tools for protein development and custom synthesis are offered.
amidetech.com2017Cambridge, United States$16.5M8
Automated peptide synthesis platform is developed with precision reagents.
Premium access

Detailed competitors of Aquagene

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Aquagene (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aquagene

Aquagene was founded in 1996 and raised its 1st funding round 4 years after it was founded.

Aquagene is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.

Aquagene produces high-quality recombinant proteins for research and industrial applications, focusing on providing healthcare solutions, advancing biotech innovations, recombinant proteins, and production and manufacturing. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.

Aquagene's top competitors include Encodia, Tierra Biosciences and Amide Technologies.

Aquagene has 1 investor. Key investors include Advantage Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available